These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 22333230)
1. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis]. Ren F; Wang DB; Li T Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230 [TBL] [Abstract][Full Text] [Related]
2. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis. Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of hMLH1 in the malignant transformation of ovarian endometriosis. Ren F; Wang D; Jiang Y; Ren F Arch Gynecol Obstet; 2012 Jan; 285(1):215-21. PubMed ID: 21556900 [TBL] [Abstract][Full Text] [Related]
4. Identification of differentially methylated genes in the malignant transformation of ovarian endometriosis. Ren F; Wang DB; Li T; Chen YH; Li Y J Ovarian Res; 2014 Jul; 7():73. PubMed ID: 25298284 [TBL] [Abstract][Full Text] [Related]
5. Oestrogen up-regulates DNMT1 and leads to the hypermethylation of RUNX3 in the malignant transformation of ovarian endometriosis. Wang D; Guo C; Li Y; Zhou M; Wang H; Liu J; Chen P Reprod Biomed Online; 2022 Jan; 44(1):27-37. PubMed ID: 34799276 [TBL] [Abstract][Full Text] [Related]
6. Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer. Senthong A; Kitkumthorn N; Rattanatanyong P; Khemapech N; Triratanachart S; Mutirangura A Int J Gynecol Cancer; 2014 Jan; 24(1):36-42. PubMed ID: 24304685 [TBL] [Abstract][Full Text] [Related]
7. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer. Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370 [TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis. Ponandai-Srinivasan S; Andersson KL; Nister M; Saare M; Hassan HA; Varghese SJ; Peters M; Salumets A; Gemzell-Danielsson K; Lalitkumar PGL Hum Reprod; 2018 Oct; 33(10):1924-1938. PubMed ID: 30020448 [TBL] [Abstract][Full Text] [Related]
10. The High Expression of RRM2 Can Predict the Malignant Transformation of Endometriosis. Yang B; Wang T; Li N; Zhang W; Hu Y Adv Ther; 2021 Oct; 38(10):5178-5190. PubMed ID: 34424503 [TBL] [Abstract][Full Text] [Related]
11. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Suryawanshi S; Vlad AM; Lin HM; Mantia-Smaldone G; Laskey R; Lee M; Lin Y; Donnellan N; Klein-Patel M; Lee T; Mansuria S; Elishaev E; Budiu R; Edwards RP; Huang X Clin Cancer Res; 2013 Mar; 19(5):1213-24. PubMed ID: 23362326 [TBL] [Abstract][Full Text] [Related]
12. Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis. Kobayashi H; Yamada Y; Kawahara N; Ogawa K; Yoshimoto C Oncol Rep; 2019 Mar; 41(3):1729-1738. PubMed ID: 30592289 [TBL] [Abstract][Full Text] [Related]
13. Elevated RON protein expression in endometriosis and disease-associated ovarian cancers. Xu P; Ding S; Zhu L; Le F; Huang X; Tian Y; Zhang X Arch Gynecol Obstet; 2017 Mar; 295(3):631-639. PubMed ID: 27888297 [TBL] [Abstract][Full Text] [Related]
14. Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma. Murakami K; Kanto A; Sakai K; Miyagawa C; Takaya H; Nakai H; Kotani Y; Nishio K; Matsumura N Mod Pathol; 2021 Nov; 34(11):2071-2079. PubMed ID: 34172890 [TBL] [Abstract][Full Text] [Related]
15. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910 [TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of GLI1 and Shh in the malignant transformation of ovarian endometriosis]. Zhao F; Yu XP; Zhao H; Song BB; Lyu AW; Zhang SH; Wang LM Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):125-132. PubMed ID: 35184473 [No Abstract] [Full Text] [Related]
17. Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas. Matsumoto T; Yamazaki M; Takahashi H; Kajita S; Suzuki E; Tsuruta T; Saegusa M Am J Clin Pathol; 2015 Sep; 144(3):452-63. PubMed ID: 26276776 [TBL] [Abstract][Full Text] [Related]
18. [Expression of steroidogenic factor 1 in ovarian endometriosis and adenomyosis]. Xue Q; Bai L; Li T; Dong Y; Zhang Y; Zhou YF Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):831-3. PubMed ID: 22333232 [TBL] [Abstract][Full Text] [Related]
19. Hypomethylation of the GSTM1 promoter is associated with ovarian endometriosis. Zhao J; Wang L; Li Y; Zhao W; Kang S Hum Reprod; 2019 May; 34(5):804-812. PubMed ID: 30989213 [TBL] [Abstract][Full Text] [Related]
20. Increased Expression of Interleukin 37 in the Eutopic and Ectopic Endometrium of Patients With Ovarian Endometriosis. Jiang JF; Deng Y; Xue W; Zheng TP; Sun AJ Reprod Sci; 2016 Feb; 23(2):244-8. PubMed ID: 26342048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]